Raquel Ferrandis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raquel Ferrandis has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Juan Vicente Llau
Department of Anesthesiology and Post-surgical Critical Care, University Hospital Doctor Peset, Valencia, Spain
14 shared publications F. Hidalgo
Servicio de Anestesiología y Reanimación, Clínica Universidad de Navarra, Pamplona, Navarra, España
5 shared publicationsJ.V. Llau
Departamento de Anestesiología y Cuidados Críticos, Hospital Universitario Doctor Peset, Valencia, Spain
5 shared publicationsA. Gómez-Luque
Servicio de Anestesiología y Reanimación, Hospital Univesitario Virgen de la Victoria, Málaga, España
4 shared publicationsAurelio Gómez-Luque
Department of Anaesthesiology and Critical Care, Hospital Virgen de la Victoria, Malaga, Spain
4 shared publications- Luis Miguel Torres
Department of Anesthesiology and Reanimation, Puerta del Mar University Hospital, Cádiz, Spain
4 shared publications
Latest Publications
- 1 August 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 425-426
HEMOMAS-II, la actualización del manejo de la hemorragia masiva
- 1 August 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 425-426
HEMOMAS-II, la actualización del manejo de la hemorragia masiva
- Open Access
- 22 March 2022
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 70 (3) , 129-139
Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
- 22 March 2022
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 70 (3) , 129-139
Open AccessEficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
- 1 October 2021
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 127 (4) , e143-e145
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
- 1 October 2021
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 127 (4) , e143-e145
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
- Open Access
- 16 April 2020
- Published by Georg Thieme Verlag KG in TH Open
- Vol. 04 (02) , e127-e137
Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
Introduction There is scarce real-world experience regarding direct oral anticoagulants (DOACs) perioperative management. No study before has linked bridging therapy or DOAC-free time (pre-plus postoperative time without DOAC) with outcome. The aim of this study was to investigate real-world management and outcomes. Methods RA-ACOD is a prospective, observational, multicenter registry of adult patients on DOAC treatment requiring surgery. Primary outcomes were thrombotic and hemorrhagic complications. Follow-up was immediate postoperative (24–48 hours) and 30 days. Statistics were performed using a univariate and multivariate analysis. Data are presented as odds ratios (ORs [95% confidence interval]). Results From 26 Spanish hospitals, 901 patients were analyzed (53.5% major surgeries): 322 on apixaban, 304 on rivaroxaban, 267 on dabigatran, 8 on edoxaban. Fourteen (1.6%) patients suffered a thrombotic event, related to preoperative DOAC withdrawal (OR: 1.57 [1.03–2.4]) and DOAC-free time longer than 6 days (OR: 5.42 [1.18–26]). Minor bleeding events were described in 76 (8.4%) patients, with higher incidence for dabigatran (12.7%) versus other DOACs (6.6%). Major bleeding events occurred in 17 (1.9%) patients. Bridging therapy was used in 315 (35%) patients. It was associated with minor (OR: 2.57 [1.3–5.07]) and major (OR: 4.2 [1.4–12.3]) bleeding events, without decreasing thrombotic events. Conclusion This study offers real-world data on perioperative DOAC management and outcomes in a large prospective sample size to date with a high percentage of major surgery. Short-term preprocedural DOAC interruption depending on the drug, hemorrhagic risk, and renal function, without bridging therapy and a reduced DOAC-free time, seems the safest practice. R.F. and J.V.L. contributed toward: (1) conception and design, acquisition of data, and analysis and interpretation of data; (2) drafting the article and revising it critically for important intellectual content; (3) final approval of the version to be published; (4) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. F.J.S., M.C.C., O.G.L., M.S.M., V.S., P.G., L.M.T., E.F.B., C.G.C., P.S., M.B., N.M., C.M.E., M.L., A.G.L., J.M., F.H., G.Y., R.R., B.C., E.D., B.T., A.P., M.A.V., J.C.A., and S.S. contributed toward: (1) acquisition of data; (2) revising the article critically for important intellectual content; (3) final approval of the version to be published; (4) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. RA-ACOD investigators contributed toward: (1) acquisition of data; (2) final approval of the version to be published; (3) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. * A complete list of the RA-ACOD investigators is provided as [Supplementary Appendix].
- 16 April 2020
- Published by Georg Thieme Verlag KG in TH Open
- Vol. 04 (02) , e127-e137
Open AccessPeriprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
Introduction There is scarce real-world experience regarding direct oral anticoagulants (DOACs) perioperative management. No study before has linked bridging therapy or DOAC-free time (pre-plus postoperative time without DOAC) with outcome. The aim of this study was to investigate real-world management and outcomes. Methods RA-ACOD is a prospective, observational, multicenter registry of adult patients on DOAC treatment requiring surgery. Primary outcomes were thrombotic and hemorrhagic complications. Follow-up was immediate postoperative (24–48 hours) and 30 days. Statistics were performed using a univariate and multivariate analysis. Data are presented as odds ratios (ORs [95% confidence interval]). Results From 26 Spanish hospitals, 901 patients were analyzed (53.5% major surgeries): 322 on apixaban, 304 on rivaroxaban, 267 on dabigatran, 8 on edoxaban. Fourteen (1.6%) patients suffered a thrombotic event, related to preoperative DOAC withdrawal (OR: 1.57 [1.03–2.4]) and DOAC-free time longer than 6 days (OR: 5.42 [1.18–26]). Minor bleeding events were described in 76 (8.4%) patients, with higher incidence for dabigatran (12.7%) versus other DOACs (6.6%). Major bleeding events occurred in 17 (1.9%) patients. Bridging therapy was used in 315 (35%) patients. It was associated with minor (OR: 2.57 [1.3–5.07]) and major (OR: 4.2 [1.4–12.3]) bleeding events, without decreasing thrombotic events. Conclusion This study offers real-world data on perioperative DOAC management and outcomes in a large prospective sample size to date with a high percentage of major surgery. Short-term preprocedural DOAC interruption depending on the drug, hemorrhagic risk, and renal function, without bridging therapy and a reduced DOAC-free time, seems the safest practice. R.F. and J.V.L. contributed toward: (1) conception and design, acquisition of data, and analysis and interpretation of data; (2) drafting the article and revising it critically for important intellectual content; (3) final approval of the version to be published; (4) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. F.J.S., M.C.C., O.G.L., M.S.M., V.S., P.G., L.M.T., E.F.B., C.G.C., P.S., M.B., N.M., C.M.E., M.L., A.G.L., J.M., F.H., G.Y., R.R., B.C., E.D., B.T., A.P., M.A.V., J.C.A., and S.S. contributed toward: (1) acquisition of data; (2) revising the article critically for important intellectual content; (3) final approval of the version to be published; (4) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. RA-ACOD investigators contributed toward: (1) acquisition of data; (2) final approval of the version to be published; (3) agreement to be accountable for all aspects of the work thereby ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. * A complete list of the RA-ACOD investigators is provided as [Supplementary Appendix].
- 1 March 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (3) , 119-121
Estado actual de la fluidoterapia en el paciente quirúrgico en nuestro medio. A propósito del estudio Fluid Day
- 1 March 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (3) , 119-121
Estado actual de la fluidoterapia en el paciente quirúrgico en nuestro medio. A propósito del estudio Fluid Day
- 1 March 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (3) , 149-156
Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery
- 1 March 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (3) , 149-156
Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery
- 22 February 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 66 (3) , 149-156
Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery
- 22 February 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación (English Edition)
- Vol. 66 (3) , 149-156
Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery
- 1 January 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (1) , 18-36
Recomendaciones de manejo perioperatorio de antiagregantes plaquetarios en cirugía no cardíaca. Grupo de trabajo de la Sección de Hemostasia, Medicina Transfusional y Fluidoterapia de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR). Actualización de la Guía de práctica clínica 2018
- 1 January 2019
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 66 (1) , 18-36
Recomendaciones de manejo perioperatorio de antiagregantes plaquetarios en cirugía no cardíaca. Grupo de trabajo de la Sección de Hemostasia, Medicina Transfusional y Fluidoterapia de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR). Actualización de la Guía de práctica clínica 2018
- 1 October 2018
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 65 (8) , 423-425
Perioperative and periprocedural management of antithrombotic therapy: Multidisciplinar consensus document
- 1 October 2018
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 65 (8) , 423-425
Perioperative and periprocedural management of antithrombotic therapy: Multidisciplinar consensus document